![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PDIA2 |
Gene summary for PDIA2 |
![]() |
Gene information | Species | Human | Gene symbol | PDIA2 | Gene ID | 64714 |
Gene name | protein disulfide isomerase family A member 2 | |
Gene Alias | PDA2 | |
Cytomap | 16p13.3 | |
Gene Type | protein-coding | GO ID | GO:0006457 | UniProtAcc | Q13087 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64714 | PDIA2 | HTA12-26-1 | Human | Pancreas | PDAC | 9.84e-03 | -5.31e-01 | 0.3728 |
64714 | PDIA2 | HTA12-29-1 | Human | Pancreas | PDAC | 1.59e-13 | -5.31e-01 | 0.3722 |
64714 | PDIA2 | HTA12-9-1 | Human | Pancreas | PDAC | 2.00e-05 | -5.31e-01 | 0.1532 |
64714 | PDIA2 | 3829-EC | Human | Pancreas | PanIN | 1.54e-10 | 3.78e-01 | 0.009 |
64714 | PDIA2 | 4347-EC | Human | Pancreas | PanIN | 4.68e-05 | -2.59e-01 | 0.0572 |
64714 | PDIA2 | 4741-EC1 | Human | Pancreas | PanIN | 3.85e-06 | 8.05e-01 | 0.0223 |
64714 | PDIA2 | 4741-EC2 | Human | Pancreas | PanIN | 4.17e-13 | 4.97e-01 | 0.0194 |
64714 | PDIA2 | DS20191261Tumor | Human | Pancreas | PDAC | 5.26e-07 | -5.31e-01 | 0.1367 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |